|
|
|
|
||
Re: Reminder from a PM on tilmanocept/Lymphoseek being top line in H&N..Independent trial: "Determine if panitumumab-IRDye800 can identify sentinel nodes with the >same accuracy< as technetium Tc 99m-labeled tilmanocept (Lymphoseek)."Reminders, reminders, reminders....blah, blah, blah.....old news from 2013. You sound like a broken record Money. |
return to message board, top of board |